High-intensity Focused Ultrasound in Treatment of Uterine Fibroid

Status Completed

Clinical Trial Summary

Uterine fibroids are common uterine benign neoplasm. They can cause abnormal menstrual bleeding, pelvic discomfort and urinary frequency. Although surgical intervention is the definitive treatment, some women prefer to have their uterus preserved. High-intensity focused ultrasound (HIFU) therapy is receiving increasing interest in the management of uterine fibroids by inducing focal thermocoagulation of the fibroids. Results obtained by various research groups have shown that HIFU treatment is safe, effective and is highly acceptable to patients. The main objective of this study is to evaluate the therapeutic efficacy of HIFU in the treatment of uterine fibroids.

In this proposed study, 20 patients who have symptomatic uterine fibroids who meet the study inclusion criteria will be invited to participate in the study which involves the use of HIFU in the management of the fibroid. Background information of the patients such as age, body mass index, hormonal (pre- or postmenopausal) status and the presence of chronic medical disease will be collected. Subjects will also be asked to complete an eight-item section of a Uterine Fibroid Symptom and Quality Of Life Questionnaire (UFS-QOL) which evaluate the effect of the fibroid on the quality of life of women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02954744
Study type	Interventional
Source	Queen Mary Hospital, Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	March 2012
Completion date	March 2018

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05568940` - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Terminated	`NCT02209545` - Misoprostol for Reduction of Blood Loss During Fibroid Surgery	Phase 4
Completed	`NCT00332033` - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)	Phase 2
Recruiting	`NCT04849858` - Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures	Phase 3
Terminated	`NCT00001850` - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Completed	`NCT02620748` - Use of Intravenous Tranexamic Acid During Myomectomy	Phase 1
Terminated	`NCT00710346` - Establishment of Fibroid Tissue Bank
Withdrawn	`NCT02703246` - Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes	N/A
Not yet recruiting	`NCT01347385` - Barbed Suture Versus Traditional Suture Material for Laparoscopic Myomectomy	N/A
Completed	`NCT02620345` - Fibroids in Women of Reproductive Age and Women Pregnancy	Phase 4
Completed	`NCT01581944` - Gonadotropin-releasing Hormone Agonist Prior to Myomectomy	Phase 3
Completed	`NCT04071574` - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility	Phase 1/Phase 2
Completed	`NCT02812186` - Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery	Phase 4
Recruiting	`NCT02288130` - Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy	Phase 4
Completed	`NCT04550429` - Uterine Filling Pressure in Hysteroscopy	N/A
Withdrawn	`NCT01671215` - Endometrial and Myometrial Changes, With and Without Fibroids	N/A
Completed	`NCT01936493` - Biologic Predictors of Leiomyoma Treatment Outcomes	N/A
Completed	`NCT00995878` - The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.	Phase 4